Glimepiride 1 mg + Metformin Hydrochloride 1000 mg PR Tablets – GLIMRIL M1 DUO

Glimepiride 1 mg + Metformin Hydrochloride 1000 mg PR Tablets – Optimal Blood Sugar Management, Combined Power.

GLIMRIL M1 DUO – Glimepiride 1 mg + Metformin Hydrochloride 1000 mg PR Tablets (bilayered) combines Glimepiride, a sulfonylurea that stimulates pancreatic insulin secretion, and Metformin, a biguanide that reduces hepatic glucose production and enhances insulin sensitivity. The prolonged-release (PR) formulation ensures a gradual release of Metformin, leading to stable blood sugar levels with fewer gastrointestinal side effects.

Recommended by Specialists:
✅Diabetologists – For long-term Type 2 Diabetes Mellitus (T2DM) management and insulin resistance.
✅General Physicians (GPs) – For maintaining fasting and postprandial blood sugar levels in diabetes patients.

Key Benefits of Glimepiride 1 mg + Metformin Hydrochloride 1000 mg PR Tablets – GLIMRIL M1 DUO:
✅Dual Mechanism for Optimal Blood Sugar Control – Glimepiride promotes insulin secretion, while Metformin enhances insulin sensitivity and reduces excess glucose production.
✅Bilayered Technology for Better Absorption – Ensures immediate Glimepiride release for quick action and prolonged Metformin release for sustained glucose control.
✅Reduced Risk of Gastrointestinal Side Effects – The PR formulation of Metformin minimizes stomach discomfort, making it easier to tolerate.
✅Lower Risk of Hypoglycaemia – At appropriate doses, Glimepiride has a relatively lower risk of causing low blood sugar compared to other sulfonylureas.

Indications:
✅Type 2 Diabetes Mellitus (T2DM) Management
✅Control of both Fasting & Postprandial Blood Sugar
✅Insulin Resistance in T2DM Patients
✅Stable Glycaemic Control with Reduced Side Effects